Muromonab-CD3 Clinical Trials

• Study of Muromonab-CD3 and Cyclosporine in Patients with Giant Cell Myocarditis
  ClinicalTrials.gov Identifier: NCT00027443 - Recruiting
  Myocarditis
  
• Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
  ClinicalTrials.gov Identifier: NCT00004482 - Active, not recruiting
  Myocarditis; Giant Cell Myocarditis
  
• Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
  ClinicalTrials.gov Identifier: NCT00450983 - Recruiting
  Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes
  
• Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00143559 - Active, not recruiting
  Neoplasm, leukemia, myeloid; Lymphoma, Non-Hodgkin; Stem Cell Transplantation; Myelodysplastic Syndromes; Hepatic Cancer
  
• Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00202917 - Recruiting
  Hematologic Malignancies
  
• Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00378508 - Recruiting
  Type 1 Diabetes Mellitus
  
• Allogeneic Hematopoietic Stem Cell Transplantation for Children Affected with Malignant Osteopetrosis: A Pilot Study
  ClinicalTrials.gov Identifier: NCT00145587 - Recruiting
  Malignant Osteopetrosis
  
• Treatment of Patients with Advanced Epithelial Ovarian Cancer using Anti-CD3 Stimulated Peripheral Blood Lymphocytes Transduced with a Gene Encoding a Chimeric T-Cell Receptor Reactive with Folate Binding Protein
  ClinicalTrials.gov Identifier: NCT00001494 - Completed
  Ovarian Neoplasm
  
• Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Pa
  ClinicalTrials.gov Identifier: NCT00189345 - Completed
  Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms